Introducing BrinaBioAI
Introducing BrinaBioAI – Next Generation, Non-Invasive Diagnostic for Earlier Detection.
A First-of-Its-Kind. Top Chronic Care Device of 2025.
In Partnership with Meridian Health Services Network
Chronic Disease is Rising But Detection Lags Behind and the U.S. healthcare is at a breaking point. The system is under immense strain.
A problem healthcare can no longer ignore. “Each year, over $3.7T is lost to preventable chronic conditions, driven by delayed detection, fragmented workflows, and limited capacity to act early.”
(Source: Centers for Medicare & Medicaid Services, 2023)
BrinaBioAI, developed by LD Technology and distributed under Brina Medical’s brand, is the same FDA-cleared diagnostic platform awarded by MedTech Outlook as the Top Chronic Care Medical Device of 2025, originally known as CMAT Advantage. It delivers unmatched clinical depth with low operational burden, making it scalable, adoption-ready, and designed for today’s high-pressure healthcare environments.
BrinaBioAI is an FDA 510(k)-cleared, non-invasive diagnostic platform that identifies autonomic, vascular, and lifestyle-related risks years before symptoms appear, all in a 30-minute session, with no labs, no blood draw, and no added staff.
LET’S TALK
See how BrinaBioAI fits into your hospital’s care strategy and growth goals. Schedule a no-obligation overview today
Contact Meridian HSN for more information